Morten B.
- Country
- Denmark
- Department
- Regionshospitalet Gødstrup, Hjertesygdomme
Research Overview
- Effect of Olpasiran on Major Cardiovascular Events in Patients with Atherosclerotic Cardiovascular Disease and Elevated Lipoprotein(a): A Randomized, Placebo-Controlled Study
- Inclisiran for Prevention of Major Adverse Cardiovascular Events in High-Risk Primary Prevention Patients with Atherosclerotic Cardiovascular Disease
- Randomized, Placebo‑Controlled Trial of Once‑Daily Oral Semaglutide (1.5, 4, 9 mg) for Weight Loss in Adults with Overweight or Obesity
Data & Insights
Has run more than one trial at 1127 of 1887 partner sites.
Specializations
Cardiovascular Disease Management
This investigator specializes in treating atherosclerotic cardiovascular disease (ASCVD) and conducting research on major adverse cardiovascular events (MACE). Their work encompasses preventive cardiology and innovative therapeutic approaches for reducing cardiovascular risks.
- Coronary Heart Disease
- Myocardial Infarction Prevention
- Ischemic Stroke Management
Cardiac Rhythm Disorders
The investigator focuses on treating atrial fibrillation and its complications, including research into anticoagulation strategies and prevention of cardioembolic events. Their work includes evaluation of novel therapeutic approaches for stroke prevention in cardiac patients.
- Stroke Prevention
- Systemic Embolism Management
- Anticoagulation Therapy
Metabolic Disorders
Research interests include the treatment of severe hypertriglyceridemia and dyslipidemia. The investigator studies innovative approaches to lipid management and its impact on cardiovascular outcomes.
- Lipid Management
- Triglyceride Reduction
- Heart Failure Prevention
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.